A WHO report emphasises the serious global impact of antimicrobial resistance, which exacerbates the substantial burden of ...

Biogen has announced that it has initiated a phase 3 study of investigational felzartamab in adults with primary membranous ...

Vertex Pharmaceuticals’ cystic fibrosis (CF) therapy Alyftrek (deutivacaftor/tezacaftor/vanzacaftor) has been approved by the European Commission (EC).

“ [These] strong phase 3 efficacy results are a significant milestone in our effort to reduce the burden of influenza in ...

Camera fatigue: being on camera means always being on show. This can be distracting for some individuals who are constantly ...

The European Commission (EC) has granted conditional approval to Jazz Pharmaceuticals’ Ziihera (zanidatamab) to treat a ...

Regeneron Pharmaceuticals’ Lynozyfic (linvoseltamab-gcpt) has been granted accelerated approval by the US Food and Drug ...

Alzheimer’s disease has rightly been characterised as a ‘silent pandemic’, with the number of Americans over 65 who are ...

Implementing AI in regulated industries like healthcare requires more than advanced technology. It demands strategic ...

AbbVie has announced that it will be expanding its immunology capabilities by acquiring Capstan Therapeutics for up to $2.1bn ...

The Communiqué Awards returned for its 27th year on 3 July to celebrate excellence in healthcare communications and showcase ...

As co-heads of the Communiqué Awards judging panel for the Action on Workplace DEI category, I spoke to Avril Lee, Chair of ...